gethoot.com

What it is

Hoot is a healthcare patient education and engagement platform from Hoot Health Inc. It is closer to a vertical-industry marketing automation/patient conversion tool than general-purpose SEO software. It targets high-explanation-cost scenarios such as specialty medications, clinical trials, myopia management, and dental implants, using physician-recorded videos, AI doctor clones, or AI Avatars to continue educating patients after they leave the clinic, reduce concerns, and drive treatment initiation, enrollment, or follow-up visits.

Core capabilities

The platform centers on “journey-based outreach”: at key points such as diagnosis, treatment decision-making, prescription fulfillment, treatment start, and adherence maintenance, it automatically sends video content via SMS, RCS, and Email. RCS can support verified senders, rich media carousels, buttons, and video playback, with regular SMS as a fallback. Hoot also provides patient journey co-creation, physician video production, MLR approval support, language localization, and real-time tracking of open rates, completion rates, and engagement data. The site mentions integrations with PSP, Hub, CRM, as well as CTMS, EDC, and ePRO in clinical trials, and support for Veeva Vault.

Pricing and data

The website does not disclose plans, unit pricing, or billing methods. It only provides sales entry points such as Book a Demo and Discovery Call, so pricing is likely enterprise-customized or project-based. The pages cite a large amount of industry data, such as specialty prescription abandonment rates, discontinuation rates, SMS open rates, and clinical trial recruitment failure rates. However, Hoot does not clearly disclose its own patient scale, number of physicians, annual message volume, or independently verified results.

Pros and cons

Its strength lies in a very focused positioning: it captures the key asset of “physician trust” in medical decision-making and lowers the barrier for patients through SMS and email. It also covers content production, compliance approval, and system integration, making it suitable for the complex workflows of pharmaceutical companies and healthcare organizations. The limitations are opaque pricing, case results that are mostly marketing-oriented, and a lack of sufficiently verifiable quantitative project details. It also depends heavily on internal data, compliance approvals, and system integrations, so implementation may require a longer timeline.

Who it is for and access from China

It is best suited for pharmaceutical patient support, medical affairs, and commercialization teams; clinical trial operations teams; and ophthalmology, dental, and other clinics looking to improve conversion for high-value services. The source text does not provide information on access from China, so the status is unknown. For deployment in China, key issues to assess include cross-border access, SMS/RCS availability, patient privacy compliance, payment, and contracting entities. Alternative approaches could include a combination of medical CRM, WeCom, SMS providers, and local patient education content systems.